In circumstances where an individual has received two doses of Nuvaxovid for their primary vaccination course, they may be offered Nuvaxovid for their first booster dose. This booster dose should be given at least 4 months after their last Nuvaxovid dose (in exceptional circumstances an interval of 3 months may be used).
If a person has been vaccinated with another type of COVID-19 vaccine for their primary course and first booster dose, and there is a contraindication or precaution to an mRNA vaccine or they have declined other COVID-19 vaccines, a booster dose of Nuvaxovid may be considered. This booster dose should be given at least 4 months after their last dose of a COVID-19 vaccine (in exceptional circumstances an interval of 3 months may be used).
For healthy people aged 18-49 years who are receiving Nuvaxovid as their second COVID-19 booster vaccine (and who have not received a homologous Nuvaxovid primary vaccination) the booster dose should be given at least 6 months after their last dose of another type of COVID-19 vaccine or COVID-19 infection.